Recap: LeMaitre Vascular Q4 Earnings
Portfolio Pulse from Benzinga Insights
LeMaitre Vascular (NASDAQ:LMAT) reported Q4 earnings, beating estimates with an EPS of $0.38 against the expected $0.36. Revenue increased by $7.93 million year-over-year. Despite beating last quarter's EPS estimate, the share price dropped by 2.0% the following day. The company has shown a consistent pattern of surpassing EPS estimates over the past year.
February 27, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LeMaitre Vascular reported a Q4 EPS of $0.38, beating estimates and showing significant year-over-year revenue growth.
LeMaitre Vascular's Q4 earnings beat and revenue growth are positive indicators for investors, suggesting operational efficiency and market demand. Historically, beating earnings estimates has been a bullish signal for stocks, although LMAT experienced a 2.0% drop after last quarter's beat. The consistent pattern of surpassing EPS estimates over the past year, combined with significant revenue growth, suggests a positive short-term impact on LMAT's stock price, despite the previous quarter's post-earnings dip.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100